Our single-cell transcriptomic analysis further revealed a notable co-upregulation of EGR1 and ATF3 in both PMD specimens and resident MuSCs, suggesting that the EGR1-ATF3 signaling is activated during PMD progression [17]. The gene discussed is ATF3; the disease is Pelizeaus-Merzbacher spectrum disorder.